Cydan

Orphan Disease Therapy and Drug Accelerator.

Launch date

2013

Employees

Market cap

Enterprise valuation

Cambridge Massachusetts (HQ)

Date	Investors	Amount	Round
Apr 2013	New Enterprise Associates Pfizer Alexandria Equities	$16.0m	Early VC
Oct 2013	Lundbeckfonden Ventures New Enterprise Associates Bay City Capital Alexandria Equities Lundbeckfonden	$10.0m	Early VC
Oct 2017	Lundbeckfonden Ventures New Enterprise Associates Pfizer Longitude Capital Alexandria Equities	$34.0m	Early VC
Total Funding		€54.5m

Tech stackLearn more about the technologies and tools that this company uses.

Recent News about Cydan